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A B S T R A C T
Purpose: Ion channels are expressed both in the heart and in the brain, being advocated as responsible for
sudden unexpected death in epilepsy but few pathogenic mutations have been identiﬁed. We aim to
identify a novel gen associated with channelopathies and epilepsy in a family.
Methods: We assessed a family showing epilepsy concomitant with LQTS. Index case showed prolonged
QT interval. His father suffers of LQT and epilepsy. We performed a direct sequencing analysis of KCNQ1,
KCNH2, KCNE1, KCNE2 and SCN5A genes.
Results: We identiﬁed a non-synonymous heterozygousmissense pathogenicmutation (p.L273F) in exon
6 of the KCNQ1 gene. All clinically affected relatives carried the same mutation.
Conclusion: We report, for a ﬁrst time, a KCNQ1 mutation in a family suffering of both phenotypes,
suggesting that KCNQ1 genetic variations may confer susceptibility for recurrent seizure activity
increasing the risk or lead to sudden death.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.1. Introduction
In recent years, it has been suggested that pathogenic signaling
excitability could underlie both epilepsy and inherited cardiac
arrhythmias, such as long QT syndrome (LQTS) [1]. The LQTS is a
rare inherited ion channelopathy characterized by prolonged QT
interval, predisposing patients to ventricular arrhythmias that can
lead to syncope and sudden cardiac death (SCD) [2]. The threemost
prevalent genes associated with LQTS are KCNQ1 (LQT type 1),
KCNH2 (LQT type 2), and SCN5A (LQT type 3) [3]. From the clinicalAbbreviations: LQTS, long QT syndrome; SCD, sudden cardiac death; SUDEP, sudden
unexpected death in epilepsy.
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights repoint of view, LQTS may be misdiagnosed as epilepsy due to
seizures triggered by cerebral hypoperfusion during a ventricular
arrhythmia. However, some patients can be affected by LQTS and
also epilepsy caused by channel dysfunction in myocardial and
neuronal cells [4]. Hence, there has been increased interest in a
possible association between epilepsy channelopathies and cardi-
ac arrhythmias. Johnson et al. [1], identiﬁed a ‘seizure phenotype’
in about 30% of unrelated LQTS patients carrying pathogenic
variants in the KCNH2 gene. A post-mortem study in diagnosed
epileptic samples identiﬁed nearly 13% of LQTS pathogenic
variants in the KCNH2 and SCN5A genes [5]. A loss-of-function
(c.246T>C) pathogenic variation in the KCNH2 gene was also
reported in a pedigree featuring LQTS, idiopathic epilepsy, and
increased risk of sudden death, supporting a strong link between
epilepsy and LQTS [6].
Sudden unexpected death in epilepsy (SUDEP) is a catastrophic
complication of epilepsy, causing up to 20% of patient deaths.
However, the pathogenetic mechanisms of this fatal conditionserved.
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identiﬁed three cases suffering SUDEPwho carried genetic variants
in the KCNQ1 gene, but consistent relation between both entities
remains to be demonstrated [8]. To our knowledge, no report
correlates LQTS type 1 and epilepsy in humans so far. We report a
family featuring the LQTS and epilepsy due to a pathogenic variant
in the KCNQ1 gene.
2. Methods and results
A 20-year-old soccer player (III-4 in Fig. 1) was referred to our
unit after detection of prolonged QT interval in a 12-lead ECG
performed in a routine medical control (corrected QT 487 ms)
(Fig. 1). He had no family history of sudden death, but his father
had been suffering from epilepsy for several years (II-3). We
recommended him to stop playing competitive soccer, to avoid
drugs that could prolong QT interval and to start treatment with a
beta blocker (bisoprolol 5 mg/day). In the follow up visits, six
months and a year later, he remained asymptomatic.
The patient’s father (II-3 in Fig. 1), who was 47 years old, had
12-lead ECG showing a prolonged QT interval (Bazett corrected QT
of 476 mseg). He was diagnosed of focal epilepsy at the age of
16. He had prodromal symptoms seconds before losing conscious-
ness, and, just at the ﬁrst signs, he preventively placed his wallet in
his mouth to protect himself from biting. He noticed tingling
around his mouth, his hands and progressively his arms, neck and
head, with a subsequent tonic–clonic seizure. He was seizure-free
on carbamazepine until, the age of 25 years, when his neurologist
withdrawn the antiepileptic therapy. We recommended him to
avoid drugs that could prolong the QT interval and start treatment
with a beta blocker (bisoprolol 5 mg/day). In the followup visits six
months and a year later he has remained asymptomatic.
The remaining ﬁrst-degree family members were asymptom-
atic and had normal QT interval on their ECG. Patient I-1 died from
pulmonary infection at 82 years of age. Patient I-4 died from
myocardial infarction at 84 years of age.
We performed a direct sequencing analysis of KCNQ1, KCNH2,
KCNE1, KCNE2 and SCN5A genes in the proband and identiﬁed
a non-synonymous heterozygous missense pathogenic variant[(Fig._1)TD$FIG]
Fig. 1. (A) Pedigree of the family. Index case is III-4 (slanted arrow). Slashes round/squar
interval in the 12-lead ECG after clinical evaluation. Black squares indicate clinically affe
variation. Minus sign () indicates non-carrier of the genetic variation. (B) Electropher
variation p.L273F in exon 6. Note the substitution c.817C>T (p.Leu273Phe). (C) Electro
corrected QT (QTc) interval of 487 ms. (D) Electrocardiogram of patient II-3 (25 mm/s,(c.817C>T) in exon 6 of the KCNQ1 gene (Fig. 1). The variant had
been previously reported in Human Gene Mutation Database –
HGMD (http://www.hgmd.cf.ac.uk/ac/index.php), and associated
with LQTS (rs120074180, CM960899) [9,10]. The variant is
conserved in many species suggesting that this region has
structural or functional importance (http://www.uniprot.org/).
In addition, it is absent in exome variant server (http://evs.gs.
washington.edu/EVS/) and 1000 genomes (http://www.
1000genomes.org/) databases, suggesting to be an uncommon
genetic variant in the population. Finally, in silico prediction in
PROVEAN (Protein Variation Effect ANalyzer) (http://provean.jcvi.
org/index.php), Mutation Taster (http://www.mutationtaster.org/
), and PolyPhen2 (http://genetics.bwh.harvard.edu/pph2) data-
bases predicted a pathogenic/deleterious effect. No other non-
common (MAF > 1%) genetic variantswere identiﬁed in index case.
After that, a genetic test was performed in close relatives (Fig. 1).
The same variant p.L273F_KCNQ1was identiﬁed in the father of the
proband (II-3), but not in the other tested relatives.
3. Discussion
In recent years, there has been an increased interest on cardiac
alterations in patients affected by epilepsy. Despite similar
molecular pathophysiology, ion channelopathies, separation of
phenotypes may be due to organ-speciﬁc gene expression
[11,12]. So far, numerous pathogenic variants have been
identiﬁed in patients suffering cardiac arrhythmia and epilepsy,
mainly in the SCN5A and KCNH2 genes [13,14]. A study performed
inmouse lines bearing dominant pathogenic variants in the Kv1.1
Shaker-like potassium channel, associated with LQTS type 1 in
humans, showed epilepsy and premature death [15], supporting
that arrhythmogenic cardiac variants in this ion channel might
also cause epileptic changes in brain [13]. Recently, a collabora-
tive study from our group genetic variants in the KCNQ1 gene in a
large series of subjects featuring epilepsy or a family history of
sudden death, although the absence of a family study did not
allow a deﬁnite causal correlation [8]. Hence, a consistent
association between KCNQ1 and LQT/epilepsy remains to be
demonstrated.es indicate deceased members. White round/squares indicate normal corrected QT
cted by long QT syndrome and/or epilepsy. Plus sign (+) indicates carrier of genetic
ogram. DNA forward sequence of the KCNQ1 gene showing the pathogenic genetic
cardiogram of index case patient III-4 (25 mm/s, 10 mm/mV). Heart rate 89 bpm,
10 mm/mV, 50 Hz). Heart rate 80 bpm, corrected QT (QTc) interval of 476 ms.
C. Tiron et al. / Seizure 25 (2015) 65–67 67Here we report a family showing the association of epilepsy
concomitant with LQTS. In our patients, prolonged QT interval
supported the phenotype. On the other hand the genetic
pathogenicity of p.L273F_KCNQ1 has been conﬁrmed as previously
reported in LQTS cases [9,10]. In addition, the evolutionary
conservation of the residue and its absence in healthy controls
as well as in silico deleterious prediction supports its pathogenic/
deleterious role. Despite cardiac arrhythmias and epilepsy can be
misdiagnosed due to similar clinical manifestations, the father of
our proband showed clear clinic features of epilepsy with focal
onset and secondarily generalized seizure. Notably, in the series
fromPartemi et al. [8], all the 3 patients carrying a change in KCNQ1
suffered from epilepsy of focal type, according to the present case.
In this family, the variable clinical expression, with no reported
seizures in the proband may be explained by an age-dependent
expression of KCNQ1 potential pathogenic variants and/or by the
inﬂuence of additional genetic modiﬁers [16].
In summary, although our family does not necessarily provide
the deﬁnite evidence for a link between LQTS and epilepsy, it
further supports the view that KCNQ1 genetic variations may
confer susceptibility for recurrent seizure activity increasing the
risk or lead to sudden death, according to the cardiocerebral
channelopathy theory [11,17]. While further studies in large
cohorts will be needed to be performed to clarify the correlation
between cardiac and brain channelopathies, the identiﬁcation of
genetic variants which may cause SCD and epilepsy brings into
question the need of simultaneous EEG and ECG recording with
video-monitoring to elucidate a possible link between cardiac
arrhythmia and epilepsy [18].
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